Therapeutic perspectives for prion diseases in humans and animals

Open Access

Pearls provide concise, practical and educational insights into topics that span the pathogens field.

Rebeca Benavente,

Affiliation Department of Neurology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas, United States of America
⨯
Rodrigo Morales

* E-mail: Rodrigo.MoralesLoyola@uth.tmc.edu

Affiliations Department of Neurology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas, United States of America, Centro Integrativo de Biologia y Quimica Aplicada (CIBQA), Universidad Bernardo O’Higgins, Santiago, Chile

https://orcid.org/0000-0001-7766-5770

⨯

Reader Comments (0)

Prion diseases
Is the Subject Area "Prion diseases" applicable to this article?

Thanks for your feedback.
Animal prion diseases
Is the Subject Area "Animal prion diseases" applicable to this article?

Thanks for your feedback.
Antibodies
Is the Subject Area "Antibodies" applicable to this article?

Thanks for your feedback.
Antibody therapy
Is the Subject Area "Antibody therapy" applicable to this article?

Thanks for your feedback.
Cell cultures
Is the Subject Area "Cell cultures" applicable to this article?

Thanks for your feedback.
Veterinary diseases
Is the Subject Area "Veterinary diseases" applicable to this article?

Thanks for your feedback.
Toxicity
Is the Subject Area "Toxicity" applicable to this article?

Thanks for your feedback.
Vaccine development
Is the Subject Area "Vaccine development" applicable to this article?

Thanks for your feedback.